The effect of different protease inhibitors on stability of parathyroid hormone, insulin, and prolactin levels under different lag times and storage conditions until analysis
- PMID: 28133791
- PMCID: PMC6817059
- DOI: 10.1002/jcla.22144
The effect of different protease inhibitors on stability of parathyroid hormone, insulin, and prolactin levels under different lag times and storage conditions until analysis
Abstract
Introduction: Proteolytic cleavage through proteases affects peptide hormone levels, which is of particular significance when the time interval between sampling and analysis is prolonged. We evaluated the stability of parathyroid hormone, insulin, and prolactin molecules (i) with different protease inhibitors such as K2 EDTA, aprotinin, and protease inhibitor cocktail (PIC), (ii) with different lag times (6-72 hours), and (iii) under different storage temperatures (4°C vs room temperature [RT]) until analysis.
Materials and methods: Blood samples were collected into 2 sets of 5 Vacutainer® tubes (Becton Dickinson) from 10 healthy adults. Tubes 1 and 2 were plain gel separator tubes. Tubes 3, 4, and 5 contained PIC (1%), aprotinin (500 KIU/mL), and K2 EDTA, respectively. After centrifugation at 1300 g for 10 minutes, PIC added to tube 2 of each set. Samples were analyzed and then one set was stored at 4°C, whereas the other at RT until analysis at 6, 24, 48, and 72 hours. Hormone levels were determined with electrochemiluminescence immunoassay (ModularE170; Roche Diagnostics). The results were compared with desirable bias limits (DBL) from Westgard QC database.
Results: Insulin at RT decreases exceeding the DBL starting from 24 hours and K2 EDTA preserved insulin. PTH exceeded the DBL at RT for 48 hours or longer and PIC addition after centrifugation inhibited its degradation. Prolactin remained stable in all tested conditions. All parameters in the plain gel separator tubes remained within DBL when stored at 4°C until 72 hours.
Conclusions: Different proteases may degrade peptide hormones and measures should be taken to counteract these effects especially if there is a delay before analysis.
Keywords: insulin; parathyroid hormone; pre-analytical phase; prolactin; protease inhibitors.
© 2017 Wiley Periodicals, Inc.
Figures

Similar articles
-
The comparison of parathyroid hormone degradation effect by various protease inhibitors in blood specimen.Korean J Lab Med. 2009 Apr;29(2):104-9. doi: 10.3343/kjlm.2009.29.2.104. Korean J Lab Med. 2009. PMID: 19411775
-
Effect of a protease inhibitor on in vitro stability of intact parathyroid hormone.Ann Clin Biochem. 2003 Mar;40(Pt 2):188-90. doi: 10.1258/000456303763046166. Ann Clin Biochem. 2003. PMID: 12662411
-
The Stability of Intact Parathyroid Hormone (PTH) in Different Types of Blood Collection Tubes.Clin Lab. 2022 Mar 1;68(3). doi: 10.7754/Clin.Lab.2021.210421. Clin Lab. 2022. PMID: 35254038
-
A comparison of stability of chemical analytes in plasma from the BD Vacutainer® Barricor™ tube with mechanical separator versus tubes containing gel separator.J Clin Lab Anal. 2020 Feb;34(2):e23060. doi: 10.1002/jcla.23060. Epub 2019 Oct 11. J Clin Lab Anal. 2020. PMID: 31605419 Free PMC article.
-
Parathormone stability in hemodialyzed patients and healthy subjects: comparison on non-centrifuged EDTA and serum samples with second- and third-generation assays.Clin Chem Lab Med. 2017 Jul 26;55(8):1152-1159. doi: 10.1515/cclm-2016-0914. Clin Chem Lab Med. 2017. PMID: 28099122
Cited by
-
First Dimension Trap-and-Elute Combined with Second Dimension Reversed-Phase Liquid Chromatography Separation Using a Two-Dimensional-Liquid Chromatography-Tandem Mass Spectrometry System for Sensitive Quantification of Human Insulin and Six Insulin Analogs in Plasma: Improved Chromatographic Resolution and Stability Testing.J Sep Sci. 2025 Feb;48(2):e70092. doi: 10.1002/jssc.70092. J Sep Sci. 2025. PMID: 39930590 Free PMC article.
References
-
- Plebani M. Errors in laboratory medicine and patient safety: the road ahead. Clin Chem Lab Med. 2007;45:700–707. - PubMed
-
- Astion ML, Shojania KG, Hamill TR, Kim S, Ng VL. Classifying laboratory incident reports to identify problems that jeopardize patient safety. Am J Clin Pathol. 2003;120:18–26. - PubMed
-
- Rai AJ, Gelfand CA, Haywood BC, et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics. 2005;5:3262–3277. - PubMed
-
- Hsieh S, Chen R, Pan Y, Lee H. Systematical evaluation of the effects of sample collection procedures on low‐molecular‐weight serum/plasma proteome profiling. Proteomics. 2006;6:3189–3198. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical